GAC, thank you for your effort in talking to Don. I've never met Don but watching various presentations and reading posters that have been at AGMs I have the impression that Don is a down home, folksy, nice guy. His favourite phrase is "and we're excited about that". But when it comes down to the hard business questions Don always avoids them. Also, the fact that the presentations that Don gives were created by a NY company and not seriously reviewed by RVX experts is a clear sign of tardiness. Don made you feel warm and fuzzy and made you feel good but he did the "skating away on the thin ice......." job on you. Anyway, keep up your efforts on all fronts. I appreciate it very much.

The more I think about this conversation and Don's comments re the VP of IR, etc the more I realize that Don either is focused on other things (I hope...like a new partner,etc) or he is a very sloppy CEO.

GAC your point re the $50 million borrowed by Hepa has never been directly linked to the $87 million for 43% share ownership. There were opinions expressed on this but I did not see the direct link either.

Koos second paragraph says it all re the 3 big outstanding issues not being addressed in your 22 minute call with Don.

BDAZ has posted an excellent list of relevant questions for all investors. Unfortunately I don't think that many of these questions will be addressed at the AGM. As GV or Jkj say on SH the AGM will just be another rubber stamp process with formalities followed by a brief update and then he'll skate off to Christmas holidays. My POV is just my simple opinions based on being involved as an investor for 10 years in RVX.

NBB I strongly believe that Hepalink has been testing apabetalone and examining all of the related research for years. The Chinese gov't under Xi Jinping is strategic and IP is one of the central legs in their strategy. Biotech is also one of their top priorities. On a CBC show called The House today Jim Balsillie (former CEO of Research in Motion (Blackberry)) was being interviewed regarding free trade negotiations between Canada and China and he pointed out concerns that must be addressed and one was intellectual property (IP). He pointed out that China graduates .03% of their population (1,000,000) IP lawyers each year (I find that hard to believe but he said it) so this certainly suggests a major emphasis on building and protecting IP. Hepalink is not directly related to this but if acquiring leading edge IP in biotech is a gov't priority Hepa could get financial help.

We all know the next few months must resolve the 3 fundamental issues. As I stated in my last post I have been buying shares even though it is a very high risk time and I am in a cynical mood. Why did I buy?

1.     My guess is that there is a very high probability (80% plus) that the Hepa financing of $87 million will be approved, perhaps before the AGM.

2.     And I believe there is a probability of over 50% that the FA will pass.JMHO

3.     Finally (conditional probability) I believe that if the FA passes there is a high probability (say80% plus) that new financing will fall into place (a few options but no evidence that Don has got this one together).

So we'll see soon one way or the other.

Kelsee, I always appreciate your hopeful attitude.

GAC just a final thought for you. Don't let Don's charm get confused with (not) dealing with the cold hard business issues. Don has always used his charm as a way to skate away from the tough questions. To be blunt he is sloppy in the data integrity of his presentations and hawks keep their eyes focused. Thus he erodes credibility among investors.

So this is a very exciting time. GLTA

Cheers

Toinv